FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061724 [Registered on: 22/01/2024] Trial Registered Prospectively
Last Modified On: 17/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Compare ayurvedic medicine application in acne vulgaris 
Scientific Title of Study   A Randomised Control Clinical Study To Compare The Efficacy Of Jatiphaladi Lepa With Lodhradi Lepa In Management Of Mukhdushika (Acne Vulgaris). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kiran Avdhut Chaudhari  
Designation  PG Scholar  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Dept of Kayachikitsa Tilak Ayurved Mahavidyalaya Rasta peth

Pune
MAHARASHTRA
411011
India 
Phone  7709289080  
Fax    
Email  kiranchaudharin556@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sadanand vitthal Deshpande  
Designation  Professor and HOD 
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Dept of Kayachikitsa Tilak Ayurved Mahavidyalaya Rasta peth

Pune
MAHARASHTRA
411011
India 
Phone  996007113  
Fax    
Email  drsvdeshpande61@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sadanand vitthal Deshpande  
Designation  Professor and HOD 
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Dept of Kayachikitsa Tilak Ayurved Mahavidyalaya Rasta peth


MAHARASHTRA
411011
India 
Phone  996007113  
Fax    
Email  drsvdeshpande61@gmail.com  
 
Source of Monetary or Material Support  
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital  
 
Primary Sponsor  
Name  Tilak ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital  
Address  Dept of Kayachikitsa rasta peth  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kiran Avdhut Chaudhari   Tilak ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital   Dept of Kayachikitsa opd no 5 6 13 rasta peth
Pune
MAHARASHTRA 
7709289080

kiranchaudharin556@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L700||Acne vulgaris. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Jatiphaladi lepa, Reference: Yogratnakar , Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Lodharadi lepa , Reference: Yogratnakar , Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  Chronicity less than 2 years  
 
ExclusionCriteria 
Details  Pidika other than face
Using regular cosmetics  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Itching pain discharge burning pidika   0, 7 14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Comedones   21 days 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   31/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Acne is the most common skin disorder found in adolescent age group around the world. Current treatment of Acne in Modern medicine is antibiotics, Vit A, Corticosteroids, Ultraviolet radiation and lotion for the external application. Generally patients Discontinue medicine as fast result is not obtained. Resistance of drug, recurrence of Disease and shifting from one pathy to other are the main hurdles in acne management. As the young patients are beauty conscious, use of any type of cosmetics, various beauty Products, no of face wash and frequent visits to beauty parlour are common in Acne Management. These self medication make this disease chronic and though it is Kshudraroga, it becomes very difficult to treat. For this reason we have decided to treat The patient externally

- Jatiphaladi Lepa specially made for Acne Vulgaris, this lepa supresses the Acne Vulgaris, "Black Spot" "Vyang" and Nilika.It is very good for skin.

- It connects very effective drugs which plays important role for the beauty of skin. The content of Jatiphaladi Lepam make the skin healthy and glorious.

- Jatiphaladi Lepa acts as vranshodak and Ropan to skin, due to presence of jatiphala in this lepa. Extensive studies have indicated wound healing inflammation modifying action of this plant. The inflammation response Fibroblast, Proliferation, Collagenisation and Epithelisation were better with jatiphala.
 
Close